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ABSTRACT 
 
Lafora Disease (LD, OMIM 254780, ORPHA501) is a fatal neurodegenerative 
disorder characterized by the presence of glycogen-like intracellular inclusions called 
Lafora bodies and caused, in the vast majority of cases, by mutations in either EPM2A 
or EPM2B genes, encoding respectively laforin and malin. In the last years, several 
reports have revealed molecular details of these two proteins and have identified several 
processes affected in LD, but the pathophysiology of the disease still remains largely 
unknown. Since autophagy impairment has been reported as a characteristic treat in 
both Lafora disease cell and animal models, and as there is a link between autophagy 
and mitochondrial performance, we sought to determine if mitochondrial function could 
be altered in those models. Using fibroblasts from LD patients, deficient in laforin or 
malin, we found mitochondrial alterations, oxidative stress and a deficiency in 
antioxidant enzymes involved in the detoxification of reactive oxygen species (ROS). 
Similar results were obtained in brain tissue samples from transgenic mice deficient in 
either the EPM2A or EPM2B genes. Furthermore, in a proteomic analysis of brain tissue 
obtained from Epm2b-/- mice, we observed an increase in a modified form of 
peroxirredoxin-6, an antioxidant enzyme involved in other neurological pathologies, 
thus corroborating an alteration of the redox condition. These data support that 
oxidative stress produced by an increase in ROS production and an impairment of the 
antioxidant enzyme response to this stress play an important role in development of LD.  
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INTRODUCTION 
 
Progressive myoclonus epilepsy of the Lafora type (Lafora Disease; LD, OMIM 
254780, ORPHA501), first described in 1911 [1], is a rare and fatal autosomic recessive 
neurodegenerative disease that produces epileptic crises, myoclonus and absence 
seizures, ataxia and dementia. In the vast majority of patients, LD has been associated 
with mutations in two genes: EPM2A, encoding the glucan phosphatase laforin, and 
EPM2B, encoding the E3-ubiquitin ligase malin. However, the role of these two 
proteins in LD has remained elusive despite the accumulation of experimental data 
regarding the function of laforin and malin, the identification of alterations in various 
cell processes and the availability of several animal and cell models of the disease. 
Laforin and malin form a functional complex, which has been demonstrated to regulate 
the activity of proteins involved in glycogen synthesis [2-5], and laforin is the only 
human phosphatase able to dephosphorylate complex glucans [6,7]. Therefore, for 
several years LD has been linked to aberrant glycogen accumulation in neurons, in the 
so-called Lafora Bodies (LBs). LBs are glycogen-like inclusions with a higher degree of 
phosphorylation and less branched than normal glycogen, hence LBs are largely 
insoluble. Since ubiquitinated proteins, chaperones and proteasome subunits have been 
detected in LBs [8], LD can also be linked to the group of neurodegenerative 
proteinopathies. Nevertheless, the cause-effect connection of LBs with the 
neurodegenerative processes that lead to the disease are not thoroughly understood. 
Recent work has demonstrated that neuronal death in LD could be influenced not only 
by the accumulation of LBs but also by impairment in mechanisms related to protein 
clearance. For instance, endoplasmic reticulum (ER) stress is significantly increased in 
mice models of LD [9], [10-12] and molecular interactions between laforin, malin, and 
the chaperone and proteasome systems have been described [8,13]. These evidences 
point to a critical dysregulation of cellular protein homeostasis following the disruption 
of a functional laforin-malin complex that goes beyond alterations in glycogen 
metabolism regulation. In this sense, our previous work with malin knock-out mice 
(Epm2b-/-) [14] revealed a clear impairment of autophagy, previously observed in 
laforin-deficient cells [15] which correlated with neurological and behavioral 
abnormalities. Also defects in the ubiquitin-proteasome system have been found in 
Lafora disease models [16,11].  
Since both defects of autophagy and protein clearance have been related with an 
increase in reactive oxygen species (ROS) production and the consequent oxidative 
stress [17-20], we decided to analyze these parameters in LD cell and animal models. 
Oxidative stress is a process whose important role in the development of several 
neurological disorders is broadly documented [21-23] and production of ROS that 
oxidize proteins and lipids in the cells may lead to senescence and apoptosis. In many 
cases, ROS production is usually increased as a consequence of a previous 
mitochondrial malfunction, and a dysregulation of antioxidant cellular systems often 
contributes to the worsening of an already altered cell function. Thus, we started our 
approach examining mitochondrial function in Lafora disease cell models and found 
important alterations that correlated with significant increased levels of ROS and 
defects in the antioxidant response in these cells. These results were corroborated in 
brain tissue samples obtained from LD mice models. Finally, a proteomic approach in 
an Epm2b-/- mouse model identified the presence of a modified form of peroxiredoxin-
6 (Prdx6), which further suggested an impairment of the antioxidant systems. Taken 
together, these results provide evidences of an alteration of the antioxidant responses in 
LD models. 
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MATERIAL AND METHODS 
 
Mammalian cell culture  
Human fibroblasts were obtained from two patients with two different 
mutations, Y86X and R241X, in the laforin gene (EPM2A) [5] and from one patient 
with the P129H mutation in the malin gene (EPM2B) [(GM008935) from Coriell 
Institute for Medical Research (Camden, NJ, USA)], all of them with the clinical 
features of LD. For simplicity, we will name these cells as Epm2a and Epm2b, 
respectively. Control fibroblasts were matched by sex and age. The results on control 
and Epm2a fibroblasts correspond to the mean obtained from two independent healthy 
and two patient individuals (no significant differences were observed between samples 
from the two type of cells in the same group). Cells were cultured at 37 ºC in a 
humidified 5% CO2 atmosphere in MEM supplemented with 15% foetal bovine serum, 
1% MEM Amino Acids, 0.5% MEM Non-Essential Amino Acids, 1% glutamine, 1% 
vitamins, 100 units/ml penicillin and 100 µg/ml streptomycin (fibroblasts’ basal growth 
medium; low proteolysis), all from Invitrogen Life Technologies. For nutrient stress 
conditions (high proteolysis), cells were switched, after washing, from fibroblasts’ basal 
growth medium  to Krebs–Henseleit medium (118.4 mM NaCl, 4.75 mM KCl, 1.19 
mM KH2PO4, 2.54 mM MgSO4, 2.44 mM CaCl2.2H2O, 28.6 mM NaHCO3, 10 mM 
glucose) containing 10 mM Hepes, pH 7.4 and incubated for 2 h at 37 ºC. Cell viability 
and growth curves were obtained by counting the cells with a hemocytometer chamber 
and using the trypan blue exclusion test. All experiments were performed at passage 
number 10–14 to avoid culture senescence effects. 
 
Fluorescence microscopy 
Cells grown on coverslips were incubated with 75 nM MytoTracker Red for 15 
min at 37 ºC. Then, the cells were rinsed with PBS, fixed with 3.7% formaldehyde/PBS 
for 15 min at 37 ºC, washed again with PBS, mounted using Fluor-Save reagent 
(Calbiochem) and observed with an Apotome-equipped Axio Observer Z1 microscope 
(Carl Zeiss AG). 
 
Flow cytometry 
For flow cytometry analysis, cells were detached by trypsinization and cells in 
suspension (5x105 cells/ml) were incubated with the different fluorophores. 
Mitochondrial membrane potential (ΔΨm) was measured by incubating the cells with 
100 nM tetramethylrhodamine-methyl-ester (TMRM, Molecular Probes) for 15 min at 
37 ºC. TMRM was used in the redistribution mode to assess ΔΨm and, therefore, a 
reduction in TMRM fluorescence represents ΔΨm depolarization. As a ΔΨm control, 16 
h before the experiment, the protonophore carbonyl cyanide m-chlorophenylhydrazone 
(CCCP, Sigma) was added at 10 μM. For measurement of ROS production, cells were  
incubated for 30 min al 37 ºC with 2′,7′-dichlorofluorescein diacetate (2.5 μM, Sigma) 
and the emitted fluorescence for total ROS detection was measured. The emitted 
fluorescence was analyzed in 105 cells per sample by flow cytometry as described 
previously [24], using a Cytomics FC 500 Flow cytometer (Beckman Coulter).  
 
Measurements of intracellular ATP and superoxide production  
ATP was measured using the ATP bioluminescence assay kit HS II (Roche 
Applied Science). Briefly, human fibroblasts were grown in 12 well plates to 50 percent 
confluence. Then, cells were incubated in fresh medium for 3 h and intracellular ATP 
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content was measured following the manufacturer’s instructions using a Spectra Max 
M5 microplate reader (Molecular Devices, Sunnyvale, USA). Luminescence intensity 
was normalized to the protein present in each sample. 
For measurements of superoxide production, cells were grown to confluence in 6 
chamber plates for 6 days. After two washes with pre-warmed PBS medium, 2 µL/mL 
of diluted dihydroethidium (Sigma, St. Louis, USA) was added to the plate. Cells were 
incubated at 37 °C for 20 min. After two additional washes with PBS, medium was 
replaced with fresh DMEM. The fluorescence was measured using a SpectraMAX 
GEMINIS microplate reader (Molecular Devices, Sunnyvale, USA), at 530 nm of 
excitation and 610 nm of emission wavelengths. All samples were analyzed two times 
in three independent experiments. 
 
Quantitative PCR  
RNA isolation and cDNA synthesis  
Total RNA was isolated from cells using the PARISTM Protein and RNA 
Isolation System (Ambion, Austin, TX, USA) according to the manufacturer’s 
instructions. For reverse transcription reactions (RT), 1 mg of the purified RNA was 
reverse transcribed using random hexamers with the High-Capacity cDNA reverse 
transcription kit (Applied Biosystems, P/N: 4322171; Foster City, CA, USA) according 
to the manufacturer’s instructions. RT conditions comprised an initial incubation step at 
25 ºC for 10 min to allow annealing of random hexamers, followed by cDNA synthesis 
at 37 ºC for 120 min, and a final 5 min inactivation step at 95 ºC. 
 
Measurement of mRNA Levels 
The mRNA levels were determined by quantitative real-time PCR analysis using 
an ABI Prism 7900 HT Fast Real-Time PCR System (Applied Biosystems, Foster City, 
CA). Gene-specific primer pairs and probes for SOD2 (MnSOD) (Hs00167309_m1, 
Taqman® Assays, Applied Biosystems) and CAT (catalase) (Hs00989766_g1, 
Taqman® Assays, Applied Biosystems) were used together with TaqManH Universal 
PCR Master Mix (Applied Biosystems, P/N 4304437, Foster City, CA) and reverse 
transcribed sample RNA in 20 µl reaction volumes. PCR conditions were 10 min at 
95 ºC for enzyme activation, followed by 40 two-step cycles (15 sec at 95 ºC; 1 min at 
60 ºC). Expression levels of glyceraldehyde-3-phosphate dehydrogenase were measured 
in all samples to normalize differences in RNA input, RNA quality and reverse 
transcription efficiency. Each sample was analyzed in triplicate and the relative 
expression levels were calculated according to the 2-ΔΔCt method [25]. 
 
Western blotting 
Proteins in the sample were denatured using sample buffer (40 mM Tris, 15 mM 
EDTA, 0.01% bromophenol blue, 40% sucrose, 4% SDS, 10% β-mercaptoethanol) and 
heating to 95 °C for 5 min. The samples were subjected to SDS-PAGE (12% 
acrylamide) and transferred onto nitrocellulose membranes (Whatman GmbH, Dassel, 
Germany). Membranes were blocked with 5% milk in TBS-Tween for 1 h and slices of 
these membranes were incubated with the following specific antibodies: anti-catalase 
(1:1000, Sigma, St. Louis, USA), anti-GPX1 (1:750, Abcam, MA, USA), anti-MnSOD 
(1:1000, Stressgen, Ann Arbor, MI, USA), anti-CuZnSOD (1:1000, Stressgen, Ann 
Arbor, MI, USA), anti-Prdx6 (1:1000, Abcam, UK) and, as loading control, antibody 
that recognizes β-actin (1:1000, Santa Cruz BioTech, USA). Thereafter, the blots were 
washed again with TBS-Tween and further incubated for 1 h with the corresponding 
secondary antibody conjugated with horseradish peroxidase. Finally, membranes were 
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washed (3x5 min) with TBS-Tween and analyzed by chemiluminiscence (ECL Western 
Blotting Detection Reagents, GE Healthcare, UK) using an image reader LAS-4000 
(GE Healthcare, UK). Densitometry of the bands was performed using Image-J. 
 
Antioxidant enzyme activities 
Antioxidant enzyme activities were performed as previously described [22]. For 
CuZnSOD and MnSOD, a Superoxide Dismutase assay kit (Cayman, Ann Arbor, MI) 
was used, based on the reduction of the tetrazolium salt by superoxide to give rise to the 
formazan salt, which is measured at 460 nm. Catalase enzymatic activity was 
determined by a standard method based on the reaction of the enzyme with methanol in 
the presence of hydrogen peroxide to produce formaldehyde. Total glutathione 
peroxidase activity was measured with a glutathione peroxidase assay kit (Cayman, Ann 
Arbor, MI) following the manufacturer’s instructions. All spectrophotometric 
measurements were carried out using a spectrophotometer SpectraMAX PLUS384 
(Molecular Devices, Sunnyvale, CA, USA). 
 
Measurement of lipid peroxide MDA 
Lipid peroxides were determined by measuring the final product 
malondialdehyde (MDA). 10 mg of brain tissue were homogenized in 100 µL of 0.05 M 
potassium phosphate buffer, 1 mM EDTA pH 7.4. For plasma samples, 50 µL were 
used. Tissue homogenates and plasma samples were deproteinized using 2.5 mL of 20% 
trichloroacetic acid. After centrifugation, 1 mL of  0.6% thiobarbituric acid was added 
to  the supernatant and the mixture incubated at 100 ºC during 30 min to form a MDA-
TBA adduct. The derivatized samples were separated by HPLC on a column of 
octadecyl silica gel to separate the MDA-TBA adduct from interfering chromogens. The 
adduct was eluted from the column with 50 mM phosphate buffer pH 6.8, 50% 
methanol and was spectrophotometrically quantified at 532 nm. MDA levels were 
expressed as nmol/mg protein. 
 
Generation of Epm2a and Epm2b knock-out mice 
A detailed description of the procedures that ended in the generation of the 
Epm2a-/- and Epm2b-/- mice (genetic background C57BL/6J) is provided in [26] and 
[14], respectively. Mice were maintained at the Instituto de Biomedicina de Valencia 
(IBV-CSIC, Valencia) on a light/dark 12:12 h cycle under constant temperature (23 ºC) 
with free access to water and regular chow diet (65% carbohydrate, 11% fat, 24% 
protein). Animal care and all procedures involving animals used in this study were in 
accordance with the Declaration of Helsinki principles and the guidelines from the 
Institutional Animal Care and Use Committee, and approved by the IBV-CSIC ethical 
review board. 
 
Two-dimensional differential in-gel electrophoresis (2D-DIGE) 
Sample preparation, labeling and protein separation by 2-D electrophoresis 
Brain samples from control and Epm2b-/- mice were homogenized in 1 ml of 
lysis buffer containing 7 M urea, 2 M thiourea, 4% CHAPS, 1% dithiothreitol (DTT) 
(v/v) and 0.5% Bio-Lyte (v/v) 3-10 ampholytes (GE Healthcare). Protein concentrations 
in the supernatants were measured with the Bradford assay kit (Bio-Rad) using bovine 
serum albumin (Sigma) as standard protein. Samples were desalted and concentrated 
with the Clean up Kit (GE Healthcare) following the manufacturer´s recommendations 
and resuspended in 30 mM Tris, 7 M urea, 2 M thiourea, and 4%  CHAPS (v/v).  
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Protein samples were labeled with CyDye® fluor minimal dyes in accordance 
with the manufacturer’s protocol (Cyanine Dye, Amersham Biosciences). Immobiline 
DryStrips pH 3-10 NL of 24 cm were passively rehydrated at 20 ºC for 20 h. The Cy3- 
and Cy5-labeled samples to be separated on the same gel were pooled with an internal 
standard and mixed with an equal volume of 2X lysis buffer. Then, an anodic cup-
loading was used to load the samples in the strip for the first dimension. IEF was run by 
applying 300 V for 4 h, 1000 V for 6 h and 10000 V for 3 h using an Amersham 
Ettan™ IPGphor unit (GE Healthcare). Focused strips were equilibrated in equilibration 
buffer [(50 mM Tris-HCl pH 7.5, 6 M Urea, 30% glycerol (v/v), 2% SDS (w/v)], first 
with 2% DTT (w/v) and then with 2.5% iodoacetamide. After equilibration, strips were 
loaded on 12.5% SDS-PAGE gels in an Ettan Dalt-six separation unit (GE Healthcare) 
and run at 25 ºC in two steps: 2 W/gel for 45 min and 17 W/gel for about 5 h. All 
electrophoresis procedures were performed in the dark. The protocol was repeated in 
three independent samples from control and Epm2b-/- mice. 
 
Image Acquisition and Analysis 
The gels were scanned with a Typhoon™ TRIO (GE Healthcare). Excitation and 
emission wavelengths were chosen specifically for each of the dyes according to the 
manufacturer’s recommendations. Image and statistical analyses were performed using 
DeCyder v7.0 (DIA and BVA module). Co-detection and quantification of Cy2, Cy3 
and Cy5 signals from each gel were determined in the DIA (differential in-gel analysis) 
module with an estimated number of spots set to 10,000 and an exclusion filter to omit 
spots with Volume >30,000. Data from the DIA module were exported to the BVA 
(biological variation analysis) module where gel-to-gel matching and two-way ANOVA 
statistical calculations were performed to determine the differentially expressed spots. 
Quantitative differences were only accepted at a fold change >1.5. Statistical differences 
were calculated using Student´s t-test and significance was accepted at p<0.05. 
 
LC-MS/MS analysis (Q-TRAP 5500)  
For each spot, a total volume of 2 μl of tryptic peptides was injected with a flow 
rate of 300 nl/min in a NanoLC Ultra1D plus system (Eksigent). A trap column Acclaim 
PepMap100 (100 µm x 2 cm; C18, 2 µm, 100 Å) and an analytical column Acclaim 
PepMap RSLC (75 µm x 15 cm, C18, 5 µm, 100 Å) from Dionex were used with the 
following gradient [Buffer A (0.1% formic acid), Buffer B (100% acetonitrile); only the 
amount of Buffer B is indicated]: 0-1 min (5% B), 1-50 min (5-40% B), 50-51 min (40-
98% B), 51-55 min (98% B), 55-56 min (5% B), 56-75 min (5% B). MS analysis was 
performed on a Q-TRAP 5500 system (ABSciex) with a NanoSpray® III ion source 
(ABSciex) using Rolling Collision Energy in positive mode. MS/MS data acquisition 
was performed using Analyst 1.5.2 (AB Sciex) and submitted to PhenyxTM Software 
(GeneBio, Geneva, Switzerland) against UniprotKB/Swiss-Prot database. Phenyx 
incorporates the true probabilistic and flexible scoring system OLAV developed at 
GeneProt Inc. [27]. The search was enzymatically constrained for trypsin and allowed 
for one missed cleavage site. Further search parameters were as follows: minimum 
significant scores for Phenyx were 5 and 6 for peptides and proteins, respectively; mass 
error tolerance was 50 ppm; there were no restrictions on molecular weight and 
isoelectric point; the fixed modification was carbamidomethylation of cysteine; the 
variable modification was oxidation of methionine. 
 
Statistical analyses 
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For the statistical analysis of the results, the mean was taken as the measurement 
of the main tendency, while standard deviation was taken as the dispersion 
measurement.  A one way analysis of variance was used to determine the difference 
between groups, when analyzing superoxide levels and Western blotting densitometries 
and enzymatic activities of CuZnSOD, MnSOD, catalase and GPx1. When an 
interaction effect was found, multiple comparisons using the Student-Newman-Keuls 
method post hoc test were performed. The significance has been considered at *p<0.05, 
**p<0.01 and ***p<0.001, as indicated in each case. GraphPad Software v5.0 was used 
for statistical analysis and graphic representations. 
 
 
RESULTS 
 
Human fibroblasts from LD patients show impaired mitochondrial function and 
increased oxidative stress 
To obtain further insights into the possible consequences of the previously 
described autophagy and protein clearance impairment in LD, we analyzed under low 
and high proteolysis conditions (see Material and Methods) a series of parameters of 
mitochondrial function in human fibroblasts from LD patients carrying mutations in the 
genes encoding either laforin (EPM2A) or malin (EPM2B) (for simplicity, we named 
these samples with altered laforin and malin as Epm2a and Epm2b, respectively; see 
Material and Methods). We started these studies analyzing the mitochondrial 
appearance with the fluorescence marker MitoTracker Red. We found that the tubular 
morphology of functional mitochondria observed in control fibroblasts was lost in both 
Epm2a and Epm2b fibroblasts (Fig. 1A). In fact, mitochondria in Epm2a and Epm2b 
fibroblasts looked aggregated (Fig. 1A, center and right), a morphology that also occurs 
under conditions of apoptosis [28].  Since mitochondrial dysfunction has been related 
with an elevated production of reactive oxygen species (ROS) [29,30] and also with 
increased superoxide production [31,22], we next analyzed the mitochondrial membrane 
potential by flow cytometry using TMRhodamine (TMRM) and found that it was 
decreased in LD human fibroblasts (Fig. 1B, the mitochondrial uncoupler CCCP was 
used as a positive control). The fact that morphology and membrane potential were 
altered in both groups of fibroblasts suggests an altered mitochondrial function. To 
corroborate this, we measured ATP production and also found decreased ATP levels in 
both groups of LD fibroblasts compared with control cells, a decrease that was also 
observed when cells were grown under nutrient stress conditions (high proteolysis 
medium) (Fig. 1C). Thus, we conclude that mitochondrial function is affected in the 
fibroblasts from LD patients. 
Next, we measured ROS levels (Fig. 2A) and superoxide production (Fig. 2B) in 
LD human fibroblasts and observed a significant raise of these parameters in both 
groups of LD human fibroblasts. These increases were more evident under basal 
conditions, probably because under these conditions ROS levels and superoxide 
production are low in control cells. When these levels were enhanced by growing the 
cells under nutrient stress conditions (high proteolysis), only a slight increase in 
superoxide production was noticed, whereas no increase in the levels of ROS occurred. 
Therefore we conclude that oxidative stress is increased in the fibroblasts from LD 
patients. 
 
Antioxidant enzymatic activities are altered in LD fibroblasts 
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We next analyzed a group of antioxidant enzymes in LD fibroblasts to 
characterize the antioxidant profile in these cells. First, we determined by Western 
blotting the levels of the superoxide dismutases MnSOD and CuZnSOD, the main 
enzymes involved in the detoxification of superoxide. A significant decrease in the 
protein levels of MnSOD, the mitochondrial variant of SOD, was evident in Epm2a and 
Epm2b cells both in low and high proteolysis conditions, a decrease that could be 
explained by a reduction of the levels of mRNA (Fig. 3A and Online Resource 1), 
whereas the protein levels of cytosolic CuZnSOD were not significantly altered in LD 
fibroblasts when compared to their controls (Fig. 4A). In accordance with these results, 
the enzymatic activity of MnSOD decreased in both Epm2a and Epm2b fibroblasts (Fig. 
3B), confirming the inability of MnSOD to respond to oxidative stress. On the other 
hand, we detected an increase in the activity of the cytosolic form of SOD (CuZnSOD), 
but only in Epm2b cells growing in low proteolysis conditions (Fig. 4B). This may 
reflect either differences in the severity of the mutations present on LD fibroblasts, or 
independent functions of laforin and malin in the cell. However, there was a clear 
decrease in this activity when both Epm2a and Epm2b cells were grown under high 
proteolysis conditions (Fig. 4B). At any rate, all these results clearly suggest an altered 
response of LD cells against superoxide.  
In addition, the protein levels (Fig. 5A) and the enzymatic activity (Fig. 5B) of 
catalase, an enzyme involved in the detoxification of hydrogen peroxide, clearly 
decreased in Epm2a and Epm2b cells in both low and high proteolysis conditions (the 
decrease in protein amount was also corroborated by analyzing the mRNA levels, see 
Online Resource 1). However, in the latter conditions, the differences in enzymatic 
activity between control and LD cells were largely attenuated, probably due to a clear 
decrease of the activity of the control cells. Since hydrogen peroxide can also be 
detoxified by glutathione peroxidases (GPx), we analyzed GPx activity. We found that 
there were no differences between human LD and control fibroblasts either in the 
protein levels of the major isoform of glutathione peroxidase (GPx1) (Fig. 6A), or in the 
total GPx activity, in either low or high proteolysis conditions (Fig. 6B). In summary, 
these results suggest that Epm2a and Epm2b fibroblasts have a partially defective 
antioxidant enzymatic defense that specifically affects some of their components. 
 
Defective antioxidant response elements in LD animal models 
To get a more physiological overview of the oxidative stress conditions in LD, 
we analyzed two different models of transgenic mice deficient in laforin or malin 
(hereafter Epm2a-/- and Epm2b-/-, respectively) [14,26]. Total brain homogenates from 
3 control and 3 transgenic Epm2a-/- and Epm2b-/- mice of 7 months of age were lysed 
and mitochondrial and cytosolic superoxide dismutase activities were measured as 
described in the previous section. Although in this case we did not observe changes in 
protein levels of MnSOD or CuZnSOD (Fig. 7A), we detected a significant decrease in 
enzymatic activity for both proteins in laforin and malin deficient mice (Fig. 7B), 
suggesting that the superoxide detoxification process was affected in LD mice models. 
We next analyzed the levels of catalase and GPx (Fig. 8) and their corresponding 
enzymatic activities, but no apparent changes were obtained in these enzymes besides a 
small increase on catalase activity observed only in malin-deficient mice (Fig. 8B). 
Finally, we addressed the oxidative stress condition in these animals by 
measuring its effect on lipid peroxidation. Lipid hydroperoxides lead to a wide variety 
of by-products, one of which is malondialdehyde (MDA), considered as a reliable 
marker of chronic oxidative stress [32]. Data presented in Fig. 9 show high levels of 
MDA in plasma for Epm2b-/- mice, clearly indicating oxidative stress. On the other 
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hand, only a tendency of increasing MDA levels was detected in brain tissue samples 
for both Epm2a-/- and Epm2b-/- mice models. 
 
2D-DIGE analysis of malin-deficient mice 
To further investigate the effects of the alterations in antioxidant response 
elements observed in animal models of LD, we chose a proteomic approach consisting 
in a two-dimensional differential in-gel electrophoresis analysis (2D-DIGE) using brain 
tissue homogenates. Animals of 7 months of age were used and samples from Epm2b-/- 
and control mice (three mice per group) were processed as described in the Material and 
Methods section. Spots with at least ±1.5 fold differential change were selected for 
analysis and, under these conditions, only three spots were significantly changed (Fig. 
10A). The first one (with a 2.02 fold increase in Epm2b-/- samples) was identified as 
VDAC2 (voltage-dependent anion-selective channel protein 2), a mitochondrial 
transporter implicated in diverse epileptogenic and neurodegenerative processes [33-
35]. The two other spots (one with a 5.53 fold increase and the second with a 1.70 fold 
decrease in Epm2b-/- samples) corresponded to two different isoelectric locations of the 
same protein, peroxiredoxin-6 (Prdx6). Prdx6 is a bifunctional enzyme with peroxidase 
and phospholipase activities involved in the detoxification of hydrogen peroxides and 
lipids [36].  
Since the change in the levels of modified forms of Prdx6 were more important 
than those related to VDAC2, we sought to confirm  the observations derived from the 
2D-DIGE analysis by Western blotting using anti-Prdx6 antibody, in brain homogenates 
from 3 different control and Epm2b-/- mice, of 6 months of age. Although no clear 
differences in the total levels of Prdx6 were found (not shown), we observed a change in 
electrophoretic mobility when the samples were subjected to two-dimensional 
electrophoresis. In contrast to the brain homogenates from control mice, in which only 
one Prdx6 spot with a pI of about 6.14 was evident, an additional spot with a pI of 
approximately 5.75 was found in the samples from Epm2b-/- mice (Fig. 10B). These 
data are in agreement with other results indicating the presence of similar post-
translational modifications of Prdx6 due to oxidative stress conditions [37-39]. In 
addition, this observation confirms the data obtained in the 2D-DIGE analysis and 
supports the existence of an oxidative stress in brain tissue of Epm2b-/- mice. 
In all, the results obtained for the oxidative stress parameters analyzed in LD 
mice models are consistent with the previous study of LD fibroblasts and corroborates 
that the major antioxidant response elements are altered as a consequence of laforin or 
malin depletion. 
 
 
DISCUSSION 
 
The ethiopathology of Lafora disease has remained largely elusive, in part due to 
the high variety of its symptoms. The initial hypothesis that an abnormal glycogen 
metabolism, due to genetic alterations of the genes encoding the phosphatase laforin or 
the E3 ubiquitin ligase malin, has been enriched by novel data pointing out to an 
accumulative process in which an ER stress caused by impairment in the unfolded 
protein response, as well as alterations in protein degradation mechanisms, could be 
also relevant [10-12]. In the present work, we provide evidence that the antioxidant 
defense systems are severely and specifically affected in both cell and animal models of 
LD, probably as a consequence of the previously described impairments.  
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The brain is considered a highly sensitive tissue to oxidative damage because it 
contains a large amount of oxidizable fatty acids and its antioxidant defenses are scarce 
[40]. Oxidative stress has been previously shown in other mice models of myoclonus 
epilepsy [41], hence it is regarded as a possible event contributing to the pathogenesis of 
epilepsy [42]. Interestingly, high levels of 8-hydroxydeoxyguanosine, one of the by-
products of DNA oxidation, have been found in brain autopsies from LD patients with 
mutations in EPM2B [43]. Although mitochondrial dysfunction and oxidative stress-
related mechanisms remain obscure in epileptogenic syndromes, recent hypotheses have 
established these mechanisms as contributing factors involved in epileptogenesis and 
seizures [21], probably by altering homeostasis of intracellular calcium, affecting 
neuronal excitability and synaptic transmission [44] and contributing to an increased 
susceptibility to epileptic seizures [45]. In fact, it has been shown in animal models in 
which epilepsy is induced that mitochondrial electron transport and ATP synthesis is 
seriously compromised [46]. Our results obtained in human fibroblasts from LD 
patients, in which mitochondrial dysfunction was suspected on the basis of an altered 
mitochondrial morphology, a decreased membrane potential and a low production of 
ATP, fit also with these observations. Since mitochondrial dysfunction generates high 
superoxide production and ROS accumulation, this could be the cause of the oxidative 
stress observed in these cells. Following this line of evidence, we found in laforin- and 
malin-deficient fibroblasts an alteration in important antioxidant enzymes involved in 
the detoxification of ROS: the superoxide dismutase isoforms MnSOD, CuZnSOD and 
catalase. The levels of hydrogen peroxide in cells can also be detoxified by glutathione 
peroxidases, but we did not detect any significant changes either in protein amount or in 
enzymatic activity of these proteins. Moreover, some of these alterations were only 
observed, or were clearly enhanced, after growing cells under a nutrient stress condition 
that triggers proteolytic processes, suggesting a relationship between the increase in 
oxidative stress and the impairment of protein clearance processes previously defined 
for these experimental models. In a recent work, we described in laforin-deficient 
fibroblasts a deficiency in thioredoxin 1 (Trx1), one of the most important antioxidant 
enzymes that participates in the reduction of oxidized cysteines in proteins and also an 
alteration in its sub-cellular localization [16]. Those results also corroborate the present 
data. Defects in the specific antioxidant enzymes MnSOD and CuZnSOD were also 
found when analyzing brain tissue samples from transgenic mice deficient in laforin or 
malin: we observed decreased MnSOD and CuZnSOD activities in brain tissue of LD 
mice models. In addition, levels of MDA (a marker of lipid peroxidation) were 
increased in Epm2b-/- plasma samples, suggesting high chronic oxidative stress in this 
particular mouse model. These results further suggest that oxidative stress plays a role 
in LD and corroborates the pattern observed in LD fibroblasts.  
Since antioxidant defense systems are composed of a heterogeneous set of 
proteins and its regulation varies significantly between cell types and tissues, we 
performed a high-throughput 2D-DIGE proteomic analysis to gain a more general view 
of the proteomic alterations in malin-deficient mice. This approach revealed 
accumulation of a modified form of Prdx6, a bifunctional enzyme with peroxidase and 
phospholipase activities involved in the cellular detoxification of hydrogen peroxide 
[36]. Increase in Prdx6 expression has been documented in mice models of 
Huntington’s disease and, more recently, Prdx6 overexpression has been shown to 
accelerate the development of Alzheimer’s disease in mice [47,48]. In malin-deficient 
mice we found no increase in the total amount of Prdx6 but a difference in the relative 
distribution of its post-translationally modified forms. Similar modifications of Prdx6 
have been described in the literature being due to oxidative stress-induced alterations 
12 
 
[37-39]. Therefore, our results suggest the presence of oxidative stress conditions in the 
brain samples of Epm2b-/- mice. Proteomic analysis also revealed an increase in 
VDAC2, an outer mitochondrial membrane channel associated to different kinds of 
epilepsy [34,33]. This is consistent with an alteration in mitochondrial function and in 
oxidative stress, two processes that are tightly interrelated. As Epm2b-/- mice have 
impaired autophagy [14], our data support the hypothesis that a defective mitophagy in 
these animals may lead to the accumulation of damaged and dysfunctional mitochondria 
and a corresponding increase in intracellular ROS levels, as described in other 
pathological conditions [49].  
In summary, we propose that increase of ROS production due to mitochondrial 
dysfunction, together with a partially decreased antioxidant defense, may be important 
events in the progression of the pathophysiology of LD in humans. Our work clearly 
shows an implication of various components of the enzymatic antioxidant response in 
LD, which must be taken into account to build up a complete landscape of the 
pathophysiology of LD. Since there is evidence that antioxidant therapy may reduce 
lesions induced by oxidative stress and mitochondrial dysfunction, these results also 
open the possibility for such treatments.  
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FIG. LEGENDS 
 
Fig.1 Mitochondrial morphology, membrane potential and cellular ATP levels in 
human fibroblasts from LD patients. (A) Representative fluorescence microscopy 
images of human fibroblasts from LD patients (Epm2a and Epm2b; see Material and 
Methods) and controls incubated with MitoTracker Red for 15 min. (B) The same 
groups of cells were incubated with TMRM for 15 min and analyzed by flow cytometry 
as described in Material and Methods. CCCP treatment (16 h, 10 μM) was used as 
control of membrane potential dysfunction. Results are represented as arbitrary units 
(a.u.) and expressed in percentage relative to the control fibroblasts. (C) Intracellular 
ATP levels from LD and control human fibroblasts grown in either basal (low 
proteolysis) or nutrient stress (high proteolysis) medium were measured as described in 
Material and Methods. Error bars represent SD of three independent measurements with 
duplicate samples. Statistical significance refers to the value of control samples in each 
condition (* for low proteolysis conditions; # for high proteolysis conditions; **p<0.01 
and ***/###p<0.001) 
 
Fig. 2  Analysis of oxidative stress parameters in LD human fibroblasts. Human 
fibroblasts grown in either basal (low proteolysis) or nutrient stress (high proteolysis) 
medium were incubated 30 min with 2′,7′-dichlorofluorescein diacetate (A) for ROS 
levels or with diluted dihydroethidium (B) for mitochondrial superoxide levels, as 
described in Material and Methods. Results are shown as arbitrary units (a.u.), 
normalized to control samples. Bars represent the mean ± SD from three independent 
experiments with duplicate samples and statistical significance refers to the value of 
control samples in each condition (* for low proteolysis conditions; # for high 
proteolysis conditions; **/##p<0.01 and ***/###p<0.001) 
 
Fig. 3 Analysis of mitochondrial superoxide dismutase in LD human fibroblasts. 
(A) Protein extracts (20 µg protein) from cultured LD and control fibroblasts grown in 
either basal (low proteolysis) or nutrient stress (high proteolysis) medium were loaded 
in SDS-PAGE gels and analyzed by Western blotting using antibodies anti-MnSOD and 
anti-actin as loading control. Histograms show the quantification of various blots by 
densitometry with the values normalized to the corresponding actin levels and referred 
to the value of control samples in low proteolysis conditions. (B) MnSOD activitiy was 
measured in extracts from LD and control fibroblasts. Results represent the mean ± SD 
from three independent experiments and statistical significance refers to the value of 
control samples in each condition (* for low proteolysis conditions; # for high 
proteolysis conditions; *p<0.05 and ***/### p<0.001) 
 
Fig. 4 Analysis of cytosolic superoxide dismutase in LD human fibroblasts. (A) 
Protein extracts (20 µg protein) from cultured LD and control fibroblasts grown in 
either basal (low proteolysis) or nutrient stress (high proteolysis) medium were loaded 
in SDS-PAGE gels and analyzed by Western blotting using anti-CuZnSOD and anti-
actin as loading control. Histograms show the quantification of various blots by 
densitometry with the values normalized to the corresponding actin levels and referred 
to the value of control samples in low proteolysis conditions. (B) CuZnSOD activity 
was measured in extracts from LD and control fibroblasts. Results represent the mean ± 
SD from three independent experiments and statistical significance refers to the value of 
control samples in each condition (* for low proteolysis conditions; # for high 
proteolysis conditions; **p<0.01 and ### p<0.001) 
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Fig. 5 Analysis of catalase in LD human fibroblasts. (A) Protein extracts (20 µg 
protein) from LD and control fibroblasts grown in either basal (low proteolysis) or 
nutrient stress (high proteolysis) medium were loaded in SDS-PAGE gels and analyzed 
by Western blotting using anti-catalase and anti-actin as a loading control.  Histograms 
show the quantification of various blots by densitometry with the values normalized to 
the corresponding actin levels and referred to the value of control samples in low 
proteolysis conditions. (B) Catalase activity was analyzed as described in Material and 
Methods. Results represent the mean ± SD from three independent experiments and 
statistical significance refers to the value of control samples in each condition (* for low 
proteolysis conditions; # for high proteolysis conditions; **/##p<0.01 and *** p<0.001)   
 
Fig. 6 Analysis of glutathione peroxidase in LD human fibroblasts. (A) Protein 
extracts (20 µg protein) from cultured LD and control fibroblasts grown in either basal 
(low proteolysis) or nutrient stress (high proteolysis) medium were loaded on SDS-
PAGE gels and analyzed by Western blotting using anti-GPx1 and anti-actin as a 
loading control. Densitometry of the bands (histograms) was normalized to the actin 
levels and referred to the value of control samples in low proteolysis conditions. (B) 
Total GPx activity was analyzed in total extracts obtained from LD and control 
fibroblasts, as described in Material and Methods. Results represent the mean ± SD 
from three independent experiments 
 
Fig. 7 Analysis of mitochondrial and cytosolic superoxide dismutases in brain 
extracts from LD mice models. (A) Protein extracts (20 µg protein) obtained from 
brain homogenates of three independent wild type (WT), Epm2a-/- and Epm2b-/- mice 
were loaded in SDS-PAGE gels and analyzed by Western blotting using anti-MnSOD 
(left), anti-CuZnSOD (right), and anti-actin as loading control. Histograms show the 
quantification of various blots by densitometry with the values normalized to the 
corresponding actin levels and referred to the value of WT samples. (B) MnSOD (left) 
and CuZnSOD (right) activities were measured in extracts from brain homogenates of 
wild type (WT), Epm2a-/- and Epm2b-/- mice. Results represent the mean ± SD from 
three independent samples in each case (**p<0.01) 
 
Fig. 8 Analysis of catalase and glutathione peroxidase in brain extracts from LD 
mice models. (A) Protein extracts (20 µg protein) obtained from brain homogenates of 
three independent wild type (WT), Epm2a-/- and Epm2b-/- mice were loaded in SDS-
PAGE gels and analyzed by Western blotting using anti-catalase (left), anti-GPx1 
(right) and anti-actin as a loading control.  Histograms show the densitometry of the 
bands normalized to the actin levels and referred to the value of WT samples. (B) 
Catalase and GPx activities were analyzed as described in Material and Methods. 
Results represent the mean ± SD from three independent samples in each case 
(*p<0.05) 
 
Fig. 9 Analysis of MDA levels in plasma and brain from LD mice models. Plasma 
samples (A) and brain homogenates (B) from three independent wild type (WT), 
Epm2a-/- and Epm2b-/- mice were analyzed as described in Material and Methods, and 
MDA levels were calculated normalizing to the total protein amount in the samples. 
Results are expressed as mean ± SD from three independent samples in each case (* 
p<0.05) 
 
19 
 
Fig. 10 Proteomic analysis of brain extracts from Epm2b-/- mice. (A) Summary of 
2D-DIGE results. Graphical view of the relative expression of each spot in samples 
from control or Epm2b-/- mice, as measured by the DeCyder Differential Analysis 
Software. The correspondence between the number of each spot, the average intensity 
ratio of Epm2b-/- to control mice (Av. Ratio), the statistical t-test values and their 
identity, as determined after mass spectrometry, is summarized in the right panel (see 
Material and Methods for details). (B) Analysis of Prdx6 electrophoretic mobility in 
Epm2b-/- mice brain samples. Total brain homogenates (10 µg protein) from mice of 6 
months of age were subjected to conventional 2D electrophoresis and analyzed by 
Western blotting using anti-Prdx6 antibody. The calculated pI for each spot is indicated 
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